Zhenning Wang
Impact in
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Gastrointestinal Tumor Research and Treatment 38
-
- Cancer-related molecular mechanisms research 49
- MicroRNA in disease regulation 31
- Journals
- BMC Cancer (20 papers)Tumor Biology (14 papers)PLoS ONE (11 papers)Oncotarget (11 papers)Annals of Surgical Oncology (10 papers)
- Partner nations
- ChinaUnited StatesSaint Kitts and Nevis
In The Last Decade
Zhenning Wang
385 papers receiving 10.4k citations
Hit Papers
Peers
Comparison fields: 5 of 172
- Cancer Research 3.1k
- Gastroenterology 737
- Oncology 3.4k
- Pulmonary and Respiratory Medicine 2.8k
- Molecular Biology 4.3k
Countries citing papers authored by Zhenning Wang
This map shows the geographic impact of Zhenning Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenning Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenning Wang more than expected).
Fields of papers citing papers by Zhenning Wang
This network shows the impact of papers produced by Zhenning Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenning Wang. The network helps show where Zhenning Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenning Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 18 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 13 | |
| 9 | Circular RNA circEXOC6B Inhibits the Progression of Ovarian Cancer by Sponging miR-421 and Regulating RUS1 Expression | 2020 | 1 |
| 10 | Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics | 2020 | 1 |
| 11 | 2020 | 6 | |
| 12 | MicroRNA-421 Inhibits Apoptosis by Downregulating Caspase-3 in Human Colorectal Cancer | 2020 | 1 |
| 13 | 2020 | 22 | |
| 14 | Siva 1 Inhibits Cervical Cancer Progression and Its Clinical Prognosis Significance | 2020 | 1 |
| 15 | Investigation of Antibiotic Resistance, Serotype Distribution, and Genetic Characteristics of 164 Invasive Streptococcus pneumoniae from North China Between April 2016 and October 2017 | 2020 | 2 |
| 16 | 2019 | 23 | |
| 17 | Decreased IFIT2 Expression In Human Non-Small-Cell Lung Cancer Tissues Is Associated With Cancer Progression And Poor Survival Of The Patients | 2019 | 2 |
| 18 | 2017 | 46 | |
| 19 | 2017 | 6 | |
| 20 | Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer | 2014 | 1 |
About Zhenning Wang
Zhenning Wang is a scholar working on Gastroenterology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 397 papers that have together received 10.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (101 papers), Metastasis and carcinoma case studies (51 papers), Cancer-related molecular mechanisms research (49 papers), Gastrointestinal Tumor Research and Treatment (38 papers), Colorectal Cancer Surgical Treatments (36 papers), Colorectal and Anal Carcinomas (33 papers), MicroRNA in disease regulation (31 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (31 papers). The work is most often cited by research in Cancer Research (3.1k citations), Gastroenterology (737 citations), Oncology (3.4k citations), Pulmonary and Respiratory Medicine (2.8k citations) and Molecular Biology (4.3k citations). Zhenning Wang has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Yongxi Song, Huimian Xu, Peng Gao, Yingying Xu, Jingxu Sun, Xiaowan Chen, Junhua Zhao, Xuanzhang Huang, Zhi‐Feng Miao and Chengzhong Xing. Their work appears in journals such as BMC Cancer, Tumor Biology, PLoS ONE, Oncotarget and Annals of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.